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Hypoxia has been shown to promote inflammation, including 
the release of proinflammatory cytokines, but it is poorly in-
vestigated how hypoxia directly affects inflammasome sig-
naling pathways. To explore whether hypoxic stress modu-
lates inflammasome activity, we examined the effect of co-
balt chloride (CoCl2)-induced hypoxia on caspase-1 activa-
tion in primary mixed glial cultures of the neonatal mouse 
brain. Unexpectedly, hypoxia induced by oxygen-glucose de-
privation or CoCl2 treatment failed to activate caspase-1 in 
microglial BV-2 cells and primary mixed glial cultures. Of par-
ticular interest, CoCl2-induced hypoxic condition consid-
erably inhibited NLRP3-dependent caspase-1 activation in 
mixed glial cells, but not in bone marrow-derived macro-
phages. CoCl2-mediated inhibition of NLRP3 inflammasome 
activity was also observed in the isolated brain microglial 
cells, but CoCl2 did not affect poly dA:dT-triggered AIM2 in-
flammasome activity in mixed glial cells. Our results collec-
tively demonstrate that CoCl2-induced hypoxia may neg-
atively regulate NLRP3 inflammasome signaling in brain glial 
cells, but its physiological significance remains to be deter-
mined.
[Immune Network 2013;13(4):141-147]
INTRODUCTION
Inflammasome is assembled mainly in innate immune cells 
when the pattern-recognition receptor (PRR), such as Nod- 
like receptor (NLR) or absent in melanoma 2 (AIM2) senses 
a wide range of cytoplasmic abnormal signals derived from 
microbial infection or tissue injury (1,2). Assembled inflamma-
some then activates caspase-1, leading to the subsequent proc-
essing and secretion of interleukin-1-beta (IL-1β), which trig-
gers proinflammatory responses. Initial activation of infla-
mmasome signaling provides a primary defense against in-
vading microbes, but many recent studies have reported that 
deregulated or sustained activation of inflammasome is asso-
ciated with chronic inflammatory or metabolic diseases (3,4).
Previous investigations have also revealed that IL-1β is ele-
vated in the central nervous system (CNS) under diverse 
pathological conditions and implicated in brain injury and 
chronic neurodegenerative diseases, including Alzheimer’s 
diseases (5-7). Notably, amyloid-β, accumulated in senile pla-
ques, has been shown to activate NLRP3 inflammasome sig-
naling in microglial cells, resulting in the increased release 
of IL-1β (8). Furthermore, the deficiency of Nlrp3- or cas-
pase-1 reduces the pathogenesis of Alzheimer’s disease in a 
transgenic mouse model expressing a mutant amyloid pre-
cursor protein and a mutant presenilin 1 (9). These recent 
findings indicate that NLRP3 inflammasome is a crucial signal-
ing axis responsible for inflammation-mediated neurotoxicity, 
leading to the neurodegenerative diseases.
Hypoxia normally occurs under many physiological con-
ditions including ischemia and organ grafts (10). Tissue hypo-
xia promotes local inflammation as evidenced by accumu-
lations of inflammatory cells and elevated levels of proin-
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flammatory cytokines (11). In particular, the brain is highly 
susceptible to hypoxic or ischemic neuronal damage in case 
cerebral blood flow is temporarily blocked (12). Excitotoxicity 
and oxidative stress are mainly responsible for hypoxic or is-
chemic neuronal cell death (13), but inflammation, primarily 
by activated microglial cells, also plays a crucial role in ex-
acerbating hypoxic brain injury (14). Indeed, previous reports 
have demonstrated that caspase-1 is critical for neuronal cell 
death under hypoxic or ischemic stress (15,16). However, it 
is still unclear whether hypoxia could stimulate or potentiate 
assembly of the inflammasome complex and subsequent acti-
vation of caspase-1, especially in brain glial cells. In this study, 
we thus examined the effect of hypoxia on inflammasome ac-
tivation in mixed glial cells from the neonatal mouse brain. 
MATERIALS AND METHODS
Cell culture and treatment
Mouse primary mixed glial cells were isolated and cultured 
as described previously (12). Briefly, the whole brain from 
pups on the first postnatal day was isolated and the meninges 
were removed in chilled Hanks’ balanced salt solution. The 
brain was then dissociated in DMEM/F-12 medium containing 
trypsin-EDTA and incubated in 5% CO2 for 12 min. The brain 
homogenate was centrifuged and filtered by using a cell 
strainer (100μm). Dissociated cells were washed and plated 
onto a 100-mm culture dish, and the medium was replaced 
every 3 days for 2∼3 weeks. To isolate microglial cells, the 
above brain-mixed cultures were agitated for 8 h, and the li-
berated cell fraction was used for microglial cells. Mouse im-
mortalized bone marrow-derived macrophages were prepared 
as described previously (17). To induce oxygen-glucose dep-
rivation (OGD), culture medium was replaced with glu-
cose-free DMEM, and the cells were placed in a humidified 
37oC incubator containing a mixture of 95% N2 and 5% CO2 
for the indicated times. 
Antibodies and reagents
Anti-human/mouse caspase-1 antibody was obtained from Santa 
Cruz (Santa Cruz, CA, USA) and kindly gifted from Dr. Emad 
Alnemri (Thomas Jefferson University). Anti-human/mouse IL-1β 
antibody was purchased from Cell Signaling Technology (Bever-
ly, MA, USA) and R&D (Minneapolis, MN, USA). All the other 
antibodies were obtained from Cell Signaling Technology 
(PARP), Alexis (San Diego, CA, NLRP3), Abcam (Cambridge, 
MA, USA, HIF-1α) and eBioscience (San Diego, CA, CD11b-PE 
and F4/80-APC). LPS, CoCl2, nigericin, ATP, and poly dA:dT 
were obtained from Sigma (St Louis, MO, USA), and z-VAD- 
fluoromethylketone was from Bachem (Torrance, CA, USA). 
All the culture media and supplements were purchased from 
Invitrogen (Grand Island, NY, USA).
Immunoblot analysis
Cells were lysed in  a buffer containing 20 mM HEPES (pH 
7.5), 0.5% NP-40, 50 mM KCl, 150 mM NaCl, 1.5 mM MgCl2, 
1 mM EGTA, and protease inhibitors. Cell lysates were frac-
tionated on SDS-PAGE, transferred onto PVDF membranes 
(BioRad, Hercules, CA, USA), and then Western-blotted using 
appropriate antibodies as indicated. Cell culture supernatants 
were precipitated by methanol/chloroform as described pre-
viously (17) and immunoblotted with appropriate antibodies.
Flow cytometric analysis
To quantitate microglial cell population, cells were stained 
with anti-CD11b-PE and anti-F4/80-APC antibodies, and ana-
lyzed by flow cytometry. To detect mitochondrial ROS, cells 
were stained with MitoSox (Invitrogen) according to the man-
ufacturer’s protocol and analyzed by flow cytometry. 
RESULTS
Hypoxia does not stimulate caspase-1 activation
To test whether hypoxia or ischemia could trigger inflamma-
some signaling in brain microglial cells, we first observed cas-
pase-1 processing in microglial BV-2 cells after oxygen-glu-
cose deprivation (OGD), which induces ischemia-like injury. 
Extracellular release of processed caspase-1, a crucial readout 
of inflammasome activation, was not detected even by 12-h 
duration of OGD, while the secretion of processed IL-1β was 
observed in the cultural supernatant of BV-2 cells under OGD 
conditions longer than 6 h (Fig. 1A). This result suggests that 
OGD could induce IL-1β release in a caspase-1/inflamm-
some-independent manner.
Previous reports demonstrated that OGD causes brain cell 
death of not only neuron but also microglia (18,19), suggest-
ing the possibility that the above OGD-mediated processing 
and secretion of IL-1β is due to cell death, but not to cas-
pase-1/inflammasome. Indeed, longer duration of OGD than 
8 h resulted in apoptotic cell death of BV-2 cells as de-
termined by the cleavage of PARP (Fig. 1A, lower panel). We 
thus examined whether the OGD-mediated IL-1β release is 
caspase-dependent or caspase-independent using a pan-cas-
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Figure 1. Hypoxia does not activate 
caspase-1 in BV-2 cells. Cultural su-
pernatants or lysates were immuno-
blotted as indicated. (A) BV-2 cells 
were resuspended in glucose-free 
media and incubated in hypoxic 
chamber for the indicated times. (B) 
BV-2 cells were treated with OGD as
described in (A) for 5 h in the pre-
sence or absence of zVAD (20μM). 
(C) BV-2 cells were treated with LPS
(0.25μg/ml) for 3 h, followed by 
treatment with CoCl2 (100μM) in 
the presence or absence of zVAD (20
μM) for 15 h.
Figure 2. CoCl2-induced hypoxia does
not induce caspase-1 activation in pri-
mary mixed glial cultures. (A) Immu-
noblots for the indicated antibodies in
cultural supernatants or lysates of 
brain mixed glial cells treated with LPS
(0.25μg/ml) with or without CoCl2
(100μM) for the indicated times or 
LPS followed with nigericin (5 mM, 
final 45 min) as indicated. (B) Mouse
bone marrow-derived macrophages 
were treated with LPS (0.25μg/ml) 
for 3 h, followed by treatment with
CoCl2 (100μM) or nigericin (5μM, 
45 min) as indicated. (C) PMA-differ-
entiated THP-1 cells were treated 
with CoCl2 (100μM) or LPS (0.5μ
g/ml, 6 h). Soluble lysates and su-
pernatants were immunoblotted as 
indicated antibodies. Note that the 
processed caspase-1 p10 or p20 
band is detected depending on the 
p10- or p20-specific anti-caspase-1 
antibody.
pase inhibitor zVAD. As described in the above experiment, 
only processed IL-1β, but not caspase-1, was detected in the su-
pernatants of BV-2 cells upon OGD treatment (Fig. 1B). However, 
the caspase inhibitor zVAD did not reduce the processing and 
release of IL-1β (Fig. 1B), indicating that IL-1β may be re-
leased by OGD in a caspase-independent manner.
The released IL-1β by OGD seems rather fragmented than 
processed into active IL-1β regardless of caspase activity (Fig. 
1B). All these observations suggest that ischemia may not in-
duce assembly of inflammasome and activation of caspase-1, 
but trigger nonspecific fragmentation and release of IL-1β, 
probably by cell death. Similar to the ischemia-mimicking 
OGD treatment, CoCl2-induced hypoxia did not promote cas-
pase-1 activation and IL-1β secretion in BV-2 cells, verifying 
that hypoxia is not implicated in the activation of in-
flammasome in microglial cells (Fig. 1C).
Then, we examined the effect of CoCl2 on inflammasome 
signaling in the primary mixed glial cultures. As observed in 
BV-2 cells, CoCl2 did not trigger caspase-1 activation in the 
LPS-primed mixed glial cells, whereas nigericin, a well-known 
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Figure 3. CoCl2-induced hypoxia attenuates NLRP3-dependent caspase-1 activation in primary mixed glial cultures. (A, B) Immunoblots for the 
indicated antibodies in cultural supernatants or lysates of brain mixed glial cells treated with LPS (0.25μg/ml) with or without CoCl2 (100μM) 
for 7 h, followed by treatment with ATP (5 mM, 45 min) or nigericin (5μM, 45 min), or transfected with poly dA:dT (1μg, 6 h) with or without
CoCl2 (100μM). (C) Immunoblots for the indicated antibodies in cultural supernatants or lysates of bone marrow-derived macrophages treated 
with LPS (0.25μg/ml) with or without CoCl2 (100μM) for 7 h, followed by treatment with ATP (5 mM, 45 min) or nigericin (5μM, 45 min).
NLRP3 stimulator, clearly induced the processing of caspase-1 
(Fig. 2A). CoCl2 treatment remarkably increased the mono-
meric or oligomeric level of HIF-1α, indicating that CoCl2 in-
duces hypoxic condition in brain mixed glial cultures. In con-
trast to the OGD treatment, no IL-1β was released by CoCl2 
treatment in LPS-primed mixed glial cells (Fig. 2A), demon-
strating that hypoxia is not likely to induce inflammasome 
activation. To verify these observations in other cell types 
than brain mixed glial cells, we treated LPS-primed mouse 
bone marrow macrophages and PMA-differentiated THP-1 
macrophages with CoCl2. As observed in mixed glial cultures, 
CoCl2−induced hypoxic conditions failed to activate caspase-1 
in both macrophages, but NLRP3 stimulators, such as niger-
icin and LPS, triggered a robust activation of caspase-1, (Fig. 
2B and C). All the above results indicate that hypoxia may 
not be a critical stimulus to the activation of inflammasome 
signaling. 
Hypoxia inhibits NLRP3 inflammasome in mixed glial 
cultures 
Next, we examined whether CoCl2−induced hypoxic con-
ditions facilitate or potentiate inflammasome signaling in pri-
mary mixed glial cells, as hypoxia has been implicated in the 
development of inflammation (10). Interestingly, CoCl2 did 
not potentiate, but rather inhibit ATP- or nigericin-induced 
NLRP3 inflammasome activation in LPS-primed brain mixed 
glial cells, as extracellular release of caspase-1 and IL-1β in 
their mature forms was attenuated in the presence of CoCl2 
(Fig. 3A). On the contrary, CoCl2 had no effect on AIM2 in-
flammasome activity in response to synthetic double-stranded 
DNA, poly dA:dT (17) (Fig. 3B). This observation demon-
strates that CoCl2 may unexpectedly inhibit NLRP3-mediated 
caspase-1 activation in brain mixed glial cells.
To lineate the regulative role of CoCl2 on NLRP3 in-
flammasome in bone marrow-derived macrophages, we de-
termined active caspase-1 and IL-1β in the cultural super-
natants of LPS-primed bone marrow macrophages after stim-
ulation with ATP or nigericin. Unlike mixed glial cultures, 
NLRP3 inflammasome activity was not affected by CoCl2 treat-
ment in bone marrow macrophages (Fig. 3C), indicating that 
CoCl2−induced hypoxia may play a unique inhibitory role 
on NLRP3 inflammasome of brain mixed glial cells.
Then, we determined the effect of CoCl2 at a various treat-
ment time before ATP stimulation to provide a molecular in-
sight into the regulation of NLRP3 inflammasome by CoCl2. 
As shown in Fig. 4A, longer treatment of CoCl2 than 4 h re-
duced ATP-mediated caspase-1 activation and IL-1β release, 
but 1-h treatment of CoCl2 was not sufficient to attenuate NLRP3 
inflammasome activation. This result suggests that CoCl2 might 
not directly interfere with the interaction of NLRP3 and ASC or 
with active assembly of NLRP3 inflammasome, because NLRP3 
inflammasome is activated only after ATP stimulation. We can 
infer that a new protein synthesis might be required for the 
negative regulation of NLRP3 inflammasome by CoCl2. The ef-
fect of CoCl2 was also examined with various LPS priming 
times. CoCl2 effectively attenuated NLRP3-dependent caspase-1 
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Figure 4. Time course effect of CoCl2
on the NLRP3 inflammasome act-
ivity. (A) Immunoblots for the indica-
ted antibodies in cultural superna-
tants or lysates of brain mixed glial 
cells treated with LPS (0.25 μg/ml,
7 h) with or without CoCl2 (100μM,
indicated times), followed by treat-
ment with ATP (5 mM, 45 min). 
Note that the CoCl2 of the sixth lane
was cotreated with ATP. (B) Immuno-
blots for the indicated antibodies in 
cultural supernatants or lysates of brain 
mixed glial cells treated with LPS (0.25μ
g/ml) with or without CoCl2 (100μM) 
for the indicated times, followed by 
treatment with ATP (5 mM, 45 min).
Figure 5. CoCl2-induced hypoxia reduces NLRP3-dependent caspase-1 
activation in primary microglial cells. (A) Flow cytometric analysis of 
mouse brain mixed glial cells (upper) and isolated microglial cells 
(lower) using anti-CD11b-PE and anti-F4/80 antigen-APC antibody. (B)
Immunoblots for the indicated antibodies in cultural supernatants of 
brain mixed glial cells or isolated microglial cells treated with LPS
(0.25μg/ml) with or without CoCl2 (100μM) for 7 h, followed by 
treatment with ATP (5 mM, 45 min).
activation and IL-1β release in mixed glial cultures regardless 
of LPS-priming time (Fig. 4B).
CoCl2-mediated inhibition of NLRP3 inflammasome 
occurs in brain microglial cells
In the central nervous system, microglia is the primary cell 
type responsible for recognizing abnormal molecular pattern, 
such as ATP, from tissue injury and triggering inflammatory 
responses (20). According to the previous report, microglia 
represents only 10% of the mixed glial cultures from the neo-
natal mouse brain (12). To exclude the possibility that the 
above finding was resulted from other cell types than micro-
glia, we isolated microglia from mixed glial cultures. Similar 
to the previous report, the population of microglia was 6.7% 
among the mixed glial cultures, as determined by the cell 
populations expressing both CD11b and F4/80 (Fig. 5A). In 
contrast, microglial cells were enriched by 81.6% after iso-
lation by the shaking method (Fig. 5A).
Next, we examined NLRP3 inflammasome activity in both 
mixed glial culture and isolated microglial cell. ATP-mediated 
caspase-1 activation and IL-1β release were similarly de-
creased by CoCl2 cotreatment not only in mixed glial cultures 
but also in microglial cells (Fig. 5B). This data indicates that 
CoCl2-induced hypoxia may negatively regulate NLRP3 in-
flammasome activity in brain microglial cells.
CoCl2-mediated inhibition of NLRP3 inflammasome is 
independent of mitochondrial ROS production
Although it is still unclear how NLRP3 inflammasome is acti-
vated upon a variety of stimuli including microbial toxins and 
crystalline substances, mitochondrial reactive oxygen species 
(ROS) has recently been suggested as a critical mediator facili-
tating the assembly of NLRP3 inflammasome (21). We thus 
examined whether mitochondrial ROS is important for ATP- 
induced NLRP3 inflammasome activation in brain mixed glial 
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Figure 6. Mitochondrial ROS is not critical for NLRP3 inflammasome
activation in primary mixed glial cells. (A) Flow cytometric analysis
of mouse bone marrow-derived macrophages treated with rotenone 
(10μM, 1 h) or ATP (3mM, 30 min) and stained with MitoSox. (B) 
Flow cytometric analysis of brain mixed glial cells treated with 
rotenone (10μM, 2 h) or LPS (0.25μg/ml) with or without CoCl2 (100
μM) for the indicated times, followed treatment with ATP (5 mM, 
40 min) and stained with MitoSox.
cells and whether CoCl2-mediated inhibition of NLRP3 signal-
ing is dependent on mitochondrial ROS levels. In bone mar-
row-derived macrophages, ATP treatment caused a significant 
production of mitochondrial ROS, albeit to a lesser extent 
than rotenone which specifically damages the electron trans-
port chain complex I leading to the generation of mitochon-
drial ROS (Fig. 6A). Contrary to bone marrow-derived macro-
phages, ATP failed to produce mitochondrial ROS in LPS- 
primed brain mixed glial cells (Fig. 6B), suggesting that mi-
tochondrial ROS may be dispensable for ATP-mediated cas-
pase-1 activation in mixed glial cells. Furthermore, CoCl2 had 
no effect on the generation of mitochondrial ROS (Fig. 6B). 
Taken together, CoCl2-mediated inhibition of NLRP3 infla-
mmasome activity in brain mixed glial cells seems indepen-
dent of mitochondrial ROS production.
DISCUSSION
Inflammation is primarily a defense system against microbial 
infection or tissue injury, but excessive inflammation can 
cause host cellular or tissue damage. The caspase-1/infla-
mmasome signaling pathway is activated upon a wide range 
of pathogen- or damage-associated molecular patterns and re-
sponsible for the secretion of proinflammatory cytokines IL-1β 
and IL-18 (2). Emerging evidence demonstrates that deregu-
lated inflammasome signaling is implicated not only in in-
flammatory disorders but also in metabolic diseases, including 
type II diabetes, obesity, and atherosclerosis (3,4,22). It has 
thus been of interest to elucidate molecular mechanisms by 
which inflammasome signaling is regulated in response to di-
verse stimuli.
Brain is a highly susceptible organ for inflammation- medi-
ated injury to neurons especially under hypoxic conditions af-
ter cerebral ischemia or stroke (7). It has already been re-
ported that hypoxia induces cerebral damage via triggering 
IL-1β-mediated toxicity to neurons and the deficiency or in-
activation of caspase-1 confers neuroprotection against hy-
poxic neuronal damage (7,15,23). In this regard, we expected 
that hypoxic conditions could trigger or at least potentiate the 
inflammasome/caspase-1 signaling pathway. However, our 
results demonstrated that hypoxia did not promote caspase-1 
activation but inhibited the NLRP3-mediated caspase-1 signal-
ing pathway.
So far, it is not well investigated whether hypoxic stimuli 
directly regulate the inflammasome signaling pathway. On the 
basis of previous results, hypoxic or ischemic injury defini-
tively induces necrotic cell death in the brain, and released 
danger-associated molecular patterns from necrotic cells might 
activate the NLRP3 inflammasome signaling pathway, leading 
to the initiation of inflammatory responses (23). Therefore, in-
hibition of caspase-1-mediated signaling could diminish neu-
rotoxicity from hypoxia-induced IL-1β. Nevertheless, this 
study proposed that hypoxia itself did not directly activate the 
caspase-1/inflammasome signaling pathway in brain mixed 
glial cells containing microglia but rather provided a negative 
regulation of NLRP3 inflammasome. At present, it is not well 
understood why hypoxia inhibits the inflammasome signaling 
in brain mixed glial cells. Therefore, it needs to be clarified 
by further investigation to provide a molecular insight ex-
plaining this phenomenon.
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